Illinois Tech-led BioCAT at Argonne National Laboratory’s Advanced Photon Source secured a $2.6 million renewal award from NIH’s National Institute of General Medical Sciences (NIGMS). The funding will sustain operations at Sector 18-ID, supporting ongoing access to cryogenic and advanced x-ray beamline experiments used in structural biology and biophysics. The renewal matters for drug discovery tooling because structural biology capabilities—especially high-resolution x-ray diffraction—underpin target validation, ligand design, and mechanism-of-action studies across therapeutic areas. For the broader ecosystem, continued NIH beamline investment maintains continuity of instrumentation access for academic and industry users, reducing downtime risk for time-sensitive research schedules.